Další formáty:
BibTeX
LaTeX
RIS
@article{2211830, author = {Bratová, Monika and Brat, Kristián and Jakubíková, Lenka}, article_location = {Praha}, article_number = {3}, doi = {http://dx.doi.org/10.48095/ccko2022215}, keywords = {COVID-19; impact on health; lung cancer; mesothelioma}, language = {cze}, issn = {0862-495X}, journal = {Klinická onkologie}, title = {Přímé a nepříme dopady pandemie COVID-19 na pacienty s nádory plic a pleury - retrospetivní analýza dat pacientů léčených na Klinice nemocí plicních a tuberkulózy FN Brno v době 2. a 3. koronavirové vlny}, url = {https://www.prolekare.cz/casopisy/klinicka-onkologie/2022-3-4/prime-a-neprime-dopady-pandemie-covid-19-na-pacienty-s-nadory-plic-a-pleury-retrospektivni-analyza-dat-pacientu-lecenych-na-klinice-nemoci-plicnich-a-tuberkulozy-fn-brno-v-dobe-2-a-3-koronavir}, volume = {35}, year = {2022} }
TY - JOUR ID - 2211830 AU - Bratová, Monika - Brat, Kristián - Jakubíková, Lenka PY - 2022 TI - Přímé a nepříme dopady pandemie COVID-19 na pacienty s nádory plic a pleury - retrospetivní analýza dat pacientů léčených na Klinice nemocí plicních a tuberkulózy FN Brno v době 2. a 3. koronavirové vlny JF - Klinická onkologie VL - 35 IS - 3 SP - 215-221 EP - 215-221 PB - Česká lékařská společnost J. E. Purkyně SN - 0862495X KW - COVID-19 KW - impact on health KW - lung cancer KW - mesothelioma UR - https://www.prolekare.cz/casopisy/klinicka-onkologie/2022-3-4/prime-a-neprime-dopady-pandemie-covid-19-na-pacienty-s-nadory-plic-a-pleury-retrospektivni-analyza-dat-pacientu-lecenych-na-klinice-nemoci-plicnich-a-tuberkulozy-fn-brno-v-dobe-2-a-3-koronavir N2 - Background: The pandemic of COVID-19 has significantly influenced the diagnostics and treatment of patients with lung and pleural malignancies. This group of patients is the riskiest, compared to patients with other cancers, both in morbidity and mortality. Study population and methods: The data of patients with lung/pleural malignancies and proved COVID-19 positivity were analyzed at the Department of Respiratory Diseases and Tuberculosis, University Hospital Brno, during the period from October 2020 to May 2021. Demographic data, information about the course of SARS-CoV-2 infection and oncological disease as well as mortality were monitored. Together with the data from the study population, three case reports are also presented. Results: Fifty-three patients were found (79% males), mean age 69.4 years, mainly with adenocarcinoma histology. A total of 47.1% patients experienced mild course of SARS-CoV-2 infection, 56.6% needed hospitalization, 24.5% died. Active anticancer treatment was delayed in 62.4% cases due to SARS-CoV-2 infection; the mean time of the delay reached 14.5 days. Conclusion: Patients with lung and pleural malignancies have a high risk of severe course of SARS-CoV-2 infection and mortality. Moreover, the ongoing SARS-CoV-2 infection as well as postcovid changes can complicate the anticancer treatment itself. © 2022, Czech Medical Association J.E. Purkyne. All rights reserved. ER -
BRATOVÁ, Monika, Kristián BRAT a Lenka JAKUBÍKOVÁ. Přímé a nepříme dopady pandemie COVID-19 na pacienty s nádory plic a pleury - retrospetivní analýza dat pacientů léčených na Klinice nemocí plicních a tuberkulózy FN Brno v době 2. a 3. koronavirové vlny. \textit{Klinická onkologie}. Praha: Česká lékařská společnost J. E. Purkyně, 2022, roč.~35, č.~3, s.~215-221. ISSN~0862-495X. Dostupné z: https://dx.doi.org/10.48095/ccko2022215.
|